Literature DB >> 16344526

Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis.

R Watson1, J E C Jepson, I Bermudez, S Alexander, Y Hart, K McKnight, A Roubertie, F Fecto, J Valmier, D B Sattelle, D Beeson, A Vincent, B Lang.   

Abstract

Rasmussen encephalitis (RE) sera were screened for antibodies to human alpha7 nicotinic acetylcholine receptors (nAChRs) using electrophysiology, calcium imaging, and ligand binding assays. Sera from two of nine patients with RE blocked ACh-induced currents through alpha7 nAChRs and the ACh-induced rise in intracellular free calcium ([Ca2+]i) and inhibited (125)I-alpha-bungarotoxin binding in cells expressing alpha7 nAChRs. Thus, the alpha7 nAChR is a potential target for pathogenic antibodies in patients with RE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344526     DOI: 10.1212/01.wnl.0000191566.86977.04

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Characterization of ganglionic acetylcholine receptor autoantibodies.

Authors:  Steven Vernino; Jon Lindstrom; Steve Hopkins; Zhengbei Wang; Phillip A Low
Journal:  J Neuroimmunol       Date:  2008-05-15       Impact factor: 3.478

Review 2.  Autoimmune encephalitis and its relation to infection.

Authors:  Arun Venkatesan; David R Benavides
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

Review 3.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

4.  Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?

Authors:  Dina Amrom; Demet Kinay; Yvonne Hart; Samuel F Berkovic; Ken Laxer; Frederick Andermann; Eva Andermann; Amit Bar-Or
Journal:  Neurology       Date:  2014-08-20       Impact factor: 9.910

Review 5.  Immunity and Inflammation in Epilepsy.

Authors:  Annamaria Vezzani; Bethan Lang; Eleonora Aronica
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

Review 6.  Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.

Authors:  Marianna Spatola; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2017-06       Impact factor: 5.710

Review 7.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

Review 8.  Autoimmune and paraneoplastic channelopathies.

Authors:  Steven Vernino
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

9.  A case of Rasmussen encephalitis treated with rituximab.

Authors:  Barbara Thilo; Robert Stingele; Karina Knudsen; Rainer Boor; Christian G Bien; Günther Deuschl; Nicolas Lang
Journal:  Nat Rev Neurol       Date:  2009-08       Impact factor: 42.937

10.  Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response.

Authors:  Geoffrey C Owens; My N Huynh; Julia W Chang; David L McArthur; Michelle J Hickey; Harry V Vinters; Gary W Mathern; Carol A Kruse
Journal:  J Neuroinflammation       Date:  2013-05-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.